Cargando…

Myeloperoxidase-Oxidized LDL Activates Human Aortic Endothelial Cells through the LOX-1 Scavenger Receptor

Cardiovascular disease as a result of atherosclerosis is a leading cause of death worldwide. Atherosclerosis is primarily caused by the dysfunction of vascular endothelial cells and the subendothelial accumulation of oxidized forms of low-density lipoprotein (LDL). Early observations have linked oxi...

Descripción completa

Detalles Bibliográficos
Autores principales:	El-Hajjar, Layal, Hindieh, Judy, Andraos, Rana, El-Sabban, Marwan, Daher, Jalil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910860/ https://www.ncbi.nlm.nih.gov/pubmed/35269979 http://dx.doi.org/10.3390/ijms23052837

Ejemplares similares

Effect of myeloperoxidase modified LDL on bovine and human aortic endothelial cells
por: El Samad, Ghadir, et al.
Publicado: (2019)

The effect of myeloperoxidase-oxidized LDL on THP-1 macrophage polarization and repolarization
por: Bazzi, Samer, et al.
Publicado: (2022)

Exposure of Endothelial Cells to Physiological Levels of Myeloperoxidase-Modified LDL Delays Pericellular Fibrinolysis
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2012)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 Signaling
por: Wang, Yun kai, et al.
Publicado: (2013)

Myeloperoxidase Oxidized LDL Interferes with Endothelial Cell Motility through miR-22 and Heme Oxygenase 1 Induction: Possible Involvement in Reendothelialization of Vascular Injuries
por: Daher, Jalil, et al.
Publicado: (2014)

Role of myeloperoxidase in inflammation and atherosclerosis (Review)
por: Frangie, Christian, et al.
Publicado: (2022)

“Affimer” synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation
por: Roper, Barnaby W.R., et al.
Publicado: (2023)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Ubiquitin-Related Modifier 1 (URM-1) Modulates Cx43 in Breast Cancer Cell Lines
por: El-Hajjar, Layal, et al.
Publicado: (2023)

Myeloperoxidase modulation by LDL apheresis in Familial Hypercholesterolemia
por: Puntoni, Mariarita, et al.
Publicado: (2011)

Data on migration of the non-invasive breast cancer cell line, MCF-7 treated with Bevacizumab using Real Time Cell Analyzer (RTCA)
por: EL-Hajjar, Layal, et al.
Publicado: (2018)

Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma
por: Moodad, Sara, et al.
Publicado: (2020)

Pannexin1 Is Associated with Enhanced Epithelial-To-Mesenchymal Transition in Human Patient Breast Cancer Tissues and in Breast Cancer Cell Lines
por: Jalaleddine, Nour, et al.
Publicado: (2019)

Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells
por: Catar, Rusan, et al.
Publicado: (2022)

Liraglutide ameliorates oxidized LDL-induced endothelial dysfunction by GLP-1R-dependent downregulation of LOX-1-mediated oxidative stress and inflammation
por: Ying, Wu, et al.
Publicado: (2023)

Reducing the Damage of Ox-LDL/LOX-1 Pathway to Vascular Endothelial Barrier Can Inhibit Atherosclerosis
por: Guo, Xiaopeng, et al.
Publicado: (2022)

Metformin regulates oxLDL-facilitated endothelial dysfunction by modulation of SIRT1 through repressing LOX-1-modulated oxidative signaling
por: Hung, Ching-Hsia, et al.
Publicado: (2016)

Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE(−/−) mouse model
por: White, Stephen J., et al.
Publicado: (2011)

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
por: Dong, Q., et al.
Publicado: (2013)

KAP1 silencing relieves OxLDL-induced vascular endothelial dysfunction by down-regulating LOX-1
por: Yan, Tianqing, et al.
Publicado: (2020)

Dyslipidemia-Induced Neuropathy in Mice: The Role of oxLDL/LOX-1
por: Vincent, Andrea M., et al.
Publicado: (2009)

MiR-590-5p Inhibits Oxidized- LDL Induced Angiogenesis by Targeting LOX-1
por: Dai, Yao, et al.
Publicado: (2016)

Molecular imaging of atherosclerotic plaque targeted to oxidized LDL receptor LOX-1 using magnetic resonance
por: Li, Dayuan, et al.
Publicado: (2009)

The LOX-1 Scavenger Receptor and Its Implications in the Treatment of Vascular Disease
por: Twigg, M. W, et al.
Publicado: (2012)

Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancer
por: El-Harakeh, Mohammad, et al.
Publicado: (2022)

Cx43 Expression Correlates with Breast Cancer Metastasis in MDA-MB-231 Cells In Vitro, In a Mouse Xenograft Model and in Human Breast Cancer Tissues
por: Kazan, Jalal M., et al.
Publicado: (2019)

Myeloperoxidase-Dependent LDL Modifications in Bloodstream Are Mainly Predicted by Angiotensin II, Adiponectin, and Myeloperoxidase Activity: A Cross-Sectional Study in Men
por: Zouaoui Boudjeltia, Karim, et al.
Publicado: (2013)

Myeloperoxidase scavenges peroxynitrite: A novel anti-inflammatory action of the heme enzyme
por: Koyani, Chintan N., et al.
Publicado: (2015)

Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
por: Abdo, Adrian I., et al.
Publicado: (2017)

Effects of copper sulfate-oxidized or myeloperoxidase-modified LDL on lipid loading and programmed cell death in macrophages under hypoxia
por: Vlaminck, Benoit, et al.
Publicado: (2014)

Ginkgolide B Reduces LOX-1 Expression by Inhibiting Akt Phosphorylation and Increasing Sirt1 Expression in Oxidized LDL-Stimulated Human Umbilical Vein Endothelial Cells
por: Ma, Lina, et al.
Publicado: (2013)

Mannose-Binding Lectin Reduces Oxidized Low-Density Lipoprotein Induced Vascular Endothelial Cells Injury by Inhibiting LOX1-ox-LDL Binding and Modulating Autophagy
por: Zhou, Xuelian, et al.
Publicado: (2023)

Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway
por: Qian, Weibin, et al.
Publicado: (2019)

28 Potential Role of Scavenger Receptors in Human Mast Cell Cytokine Response to Oxidized ldl
por: Faigerc, Rita, et al.
Publicado: (2012)

Concentration polarization of ox-LDL activates autophagy and apoptosis via regulating LOX-1expression
por: Ding, Zufeng, et al.
Publicado: (2013)

Expression of LOX-1 in human mesangial cells is increased by Ox-LDL and IL-1β treatment
por: Deng, Yinghui, et al.
Publicado: (2017)

The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation
por: Wang, Zhiwen, et al.
Publicado: (2022)

Autophagic degradation of LOX-1 is involved in the maintenance of vascular integrity injured by oxLDL and protected by Berberine
por: Zheng, Yangmin, et al.
Publicado: (2023)

Endothelial dysfunction and COVID-19 (Review)
por: Daher, Jalil
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6ulo5hqvsldnqv4hcglrlqgkq2